TFCT NIB TAB

About

TFCT NIB TAB is an oral medication classified as a targeted synthetic disease-modifying antirheumatic drug (tsDMARD), likely a kinase inhibitor. It functions by selectively modulating intracellular signaling pathways involved in immune responses and inflammation. By inhibiting specific enzymes, it helps to reduce the production of inflammatory cytokines and suppress the overactive immune system, which is characteristic of various autoimmune diseases. This precise mechanism of action aims to provide significant relief from symptoms and prevent further tissue damage.

The medication is typically used in patients who have not responded adequately to conventional therapies or who cannot tolerate them. Its therapeutic effects are observed through a reduction in pain, swelling, and stiffness, leading to improved physical function and overall quality of life. Due to its immunomodulatory effects, patients require careful monitoring for potential adverse events, including infections and other systemic complications.

Uses

• Treatment of moderate to severe rheumatoid arthritis.
• Management of active psoriatic arthritis.
• Therapy for active ankylosing spondylitis.
• Treatment of certain inflammatory bowel diseases.

Directions For Use

Take one tablet orally once or twice daily, as prescribed by your doctor. Swallow the tablet whole with water, with or without food.

Benefits

• Reduces joint inflammation and pain.
• Improves physical mobility and function.
• Slows the progression of autoimmune disease.
• Offers a targeted treatment approach.
• Reduces systemic inflammation markers.
• Enhances overall quality of life for patients.

Side Effects

• Infections (e.g., respiratory, urinary).
• Headache.
• Diarrhea.
• Nausea.
• Fatigue.
• Elevated liver enzymes.
• Increased cholesterol.
• Herpes zoster (shingles).
• Blood clots.
• Serious cardiovascular events.
• Malignancy (e.g., lymphoma, skin cancer).
• Gastrointestinal perforation.

Safety Measures

• Alcohol - Avoid or significantly limit alcohol intake due to potential increased risk of liver toxicity and other adverse effects.
• Pregnancy - Contraindicated during pregnancy due to potential teratogenic effects; women of childbearing potential must use effective contraception.
• Breastfeeding - Not recommended during breastfeeding as the drug may be excreted in breast milk and pose risks to the infant.
• Liver - Use with extreme caution in patients with hepatic impairment; dose adjustments are often necessary, and regular monitoring of liver function is essential.
• Kidney - Dosage adjustments are required for patients with moderate to severe renal impairment. Not recommended for severe kidney disease.
• Lung - Monitor for new or worsening respiratory symptoms, as there is a potential risk of interstitial lung disease or serious pulmonary infections.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.